Est. 1988 · Comprehensive Private Pharmaceutical Enterprise

Protecting Life and Health,
Driving Scientific Innovation

Shandong Yijian Pharmaceutical Co., Ltd. is located in the Seventh Industrial Park of Jining High-tech Zone — a modern pharmaceutical enterprise integrating R&D, manufacturing and sales. Guided by low cost and high feasibility, we focus on chronic-disease medicines and the translation of cutting-edge drugs, delivering high-quality medicines to grassroots healthcare.

50+ Years of Heritage
2 R&D Centers
20+ Key Pipeline Products
医药实验室研究
Dual-Center Synergy Jining Improved-Drug R&D · Jinan Frontier Translation
Excellent Quality Modern Workshops · Consecutive GMP Compliance

Deep Heritage, Modern Transformation

The company's predecessor was Factory 9839 of the Chinese People's Liberation Army, founded in 1970, restructured into a private enterprise in 1988. In 2012 it relocated in full to the High-tech Zone, rebuilding 12 major management systems spanning quality, R&D, logistics and more — a modern enterprise full of vitality.

View Our History

Dual R&D Innovation Matrix

Built on Jining R&D Center and Jinan R&D Center (Chengcheng Pharma) — a dual-center model. Backed by a senior team led by PhDs and Master's graduates, the centers conduct Category 3/4 chemical generic development and consistency evaluation, with multiple products successfully approved for market.

Explore Pipeline Progress

Advanced Capacity, Chronic-Disease Focus

Equipped with high-standard workshops for oral solid dosage forms and small-volume injections. We precisely target grassroots healthcare needs, focusing on high-incidence chronic conditions such as hypertension and diabetes, with flagship products including Amlodipine Besylate Tablets and Doxofylline Injection.

Explore Our Manufacturing Base

Product Overview

Focused on medicines for chronic and respiratory conditions, spanning tablets, capsules and injections.

丁溴东莨菪碱注射液

Scopolamine Butylbromide Injection

Digestive · Antispasmodic
二甲双胍格列本脲片(I)

Metformin / Glibenclamide Tablets (I)

Chronic Care · Glucose-Lowering
多索茶碱注射液

Doxofylline Injection

Respiratory · Antiasthmatic
铝碳酸镁咀嚼片

Hydrotalcite Chewable Tablets

Digestive · Antacid
QUALITY POLICY

Quality Risk Management Policy

We uphold the core principles of “Quality First, Prevention-Oriented, Full Participation, Continuous Improvement,”
building a life-cycle risk-control system to safeguard every life entrusted to us.

Quality Assurance System
公司版头

Grounded in Science, Devoted to Health

A modern pharmaceutical enterprise integrating R&D, manufacturing and sales

Company Overview

Shandong Yijian Pharmaceutical Co., Ltd. is located in the Seventh Industrial Park of the National High-tech Development Zone — Jining High-tech Zone. It is a comprehensive private pharmaceutical enterprise integrating R&D, manufacturing and sales. Restructured in 1988, the company has spent over three decades in the pharmaceutical industry, building deep expertise and heritage.

To meet 2010-edition GMP requirements, the company relocated in full to the Seventh Industrial Park of Jining High-tech Zone in 2012, and passed 2010 GMP certification in 2014, establishing standardized modern pharmaceutical production workshops and rebuilding 12 management systems covering production, quality, R&D, sales, logistics and more — a vibrant, modern pharmaceutical enterprise. It later built new oral solid dosage and small-volume injection workshops, and has since passed consecutive GMP compliance inspections.

1988 Restructured & Founded
GMP Certified in 2014
12 Management Systems
4 Dosage Forms
APIs · Tablets · Hard Capsules · Small-Volume Injections
56 Approval Numbers
30 Registered Trademarks
30 Patents
22 Utility Models · 8 Invention Patents

Manufacturing Capacity

Oral Solid Dosage Forms

2 Dedicated Workshops

Annual Capacity: 2.1 Billion Units

Equipped with internationally advanced fully automated lines and digital management systems, with consecutive GMP compliance.

Small-Volume Injections

2 Dedicated Workshops

Annual Capacity: 400 Million Units

Equipped with internationally advanced fully automated lines and digital management systems, with consecutive GMP compliance.

Quality Risk Management Policy

Guided by these four core principles, Yijian Pharmaceutical carries its quality commitment through every stage of R&D, manufacturing and service.

Quality First
Integrity First
Customer Satisfaction
Continuous Improvement
01

Quality First

Quality always comes first, under any circumstance. At the same time, the company pursues first-class quality management — from control systems to execution — aiming for the industry's highest standards and continuously improving pharmaceutical quality management.

02

Integrity First

Integrity is the foundation of how Yijian people conduct themselves and their work, and the most basic requirement of the revised GMP for pharmaceutical manufacturers. Without integrity, everything else is meaningless — we stand firm through every storm on a foundation of integrity.

03

Customer Satisfaction

Customer satisfaction is the company's core goal, guiding all of its activities. Any action that harms customer interests runs counter to our policy and fundamental interests. We turn our customers' trust into the driving force behind our progress.

04

Continuous Improvement

Continuous improvement is one of the most effective ways to achieve “Quality First,” and how the company keeps raising its management standard. We build a mindset of improvement into daily operations, pursuing a higher quality standard with every iteration.

Quality Management System

Full-Process Traceability

A complete quality traceability system from raw material procurement to finished product shipment, ensuring every batch can be traced.

Strict Pharmacopoeia Compliance

Laboratories strictly follow SOPs and pharmacopoeia methods such as USP and ChP, with regular internal and external audits and data integrity checks.

Instrument Calibration & Reference Standards

Rigorous instrument calibration, reference-standard management and OOS investigation procedures ensure accurate, reliable test results.

Data Integrity Principles

Following the principles of traceable, clear, contemporaneous records to ensure test data is authentic, reliable and auditable.

Market Performance

Nationwide Sales Network
销售覆盖地图 Hebei Henan Jiangsu Guangdong Fujian Guangxi Sichuan Chongqing Shandong
31 Provinces / Municipalities
2000+ Partner Hospitals
Nationwide Sales Network Coverage
2019
  • Valsartan Dispersible Tablets market share 10%
  • Omeprazole Enteric-Coated Capsules market share 15%
2021–2023
  • Valsartan Dispersible Tablets sales volume ranked No. 3 nationwide
  • Telmisartan Capsules sales volume ranked No. 2 nationwide
  • Omeprazole Enteric-Coated Capsules sales volume ranked No. 2 nationwide
2022.07
  • Nicotinamide Injection
    Won the top bid at RMB 15.77 / unit in the 3rd batch of centralized procurement led by Inner Mongolia for the “8 Provinces + 2 Regions” alliance

Honors & Qualifications

The company practices the core philosophy of “people-oriented, medicine as the bridge,” earning numerous national and provincial honors.

National High-Tech Enterprise
Shandong “Specialized, Refined, Distinctive & Innovative” SME(2023)
Technology-Based SME(2023)
Innovative SME(2023)
Jining “One Enterprise, One Technology” R&D Center(2024)
Jining Key Laboratory(2024)

Dual-Center Driven,
Full-Chain Innovation

The company operates two R&D centers covering improved new drugs, specialty generics and consistency evaluation, continuously delivering high-quality medicines to clinical practice.

研发创新特写
National-Level R&D Standards
Sustained Innovation Output
R&D Center 01

Jining R&D Center

Improved New Drugs · Specialty Generic Development

Guided by “low cost, high feasibility,” the center responds quickly to grassroots healthcare needs. It focuses on high-incidence chronic conditions such as hypertension and diabetes, conducting project research on improved new drugs and specialty generics to strengthen the company's core competitiveness in essential medicines.

Hypertension
Diabetes
Respiratory
Digestive
20+ Products in Development
Covering improved new drugs and specialty generics across chronic-disease, digestive and other common clinical fields
Key Pipeline Products (20+)
Amlodipine Besylate Tablets
Metformin Hydrochloride Sustained-Release Tablets
Esomeprazole Magnesium Enteric-Coated Capsules
Diprophylline Injection
20+ more products under continuous development
R&D Center 02

Jinan R&D Center

Shandong Chengcheng Pharmaceutical Technology Co., Ltd.

Focused on the development and translation of frontier drugs, undertaking Category 3/4 chemical generic development and quality/efficacy consistency evaluation. The center actively drives the conversion of research into commercial products — multiple products have completed registration and been successfully approved for market.

30+R&D Staff
2PhDs
15Master's
New Generic Candidates17 in total
4 Sterile Products 13 Oral Solids
  • Bumetanide Injection
  • Methocarbamol Injection
  • Phentolamine Mesylate Injection
  • Nicardipine Hydrochloride Injection
  • Vonoprazan Fumarate Tablets
  • Dapagliflozin Tablets
  • Rosuvastatin Calcium Tablets
  • Telmisartan Tablets
  • Valsartan / Amlodipine Tablets
  • Azilsartan Potassium Tablets
  • Eplerenone Tablets
  • Agomelatine Tablets
  • Valsartan Capsules
  • Sacubitril / Valsartan Sodium Tablets
  • Empagliflozin Tablets
  • Valsartan / Hydrochlorothiazide Tablets
  • Irbesartan / Hydrochlorothiazide Tablets
Consistency Evaluation in Progress6 in total
4 Sterile Products 2 Oral Solids
  • Granisetron Hydrochloride Injection
  • Aminophylline Injection
  • Clindamycin Phosphate Injection
  • Furosemide Injection
  • Telmisartan Capsules
  • Valsartan Dispersible Tablets
Approved & MarketedRegistration Completed
Doxofylline Injection
Marketed
Pentoxifylline Injection
Marketed
Lidocaine Hydrochloride Injection
Marketed
济南研发中心实拍展示

Core Product Matrix & Indications Guide

Browse Shandong Yijian Pharmaceutical's featured products below. Hover over a product image (or tap on mobile) to view its detailed indications.

Scopolamine Butylbromide Injection

Injection
丁溴东莨菪碱注射液
Indications

1. Used for pre-procedure preparation in gastric, duodenal and colonic endoscopy, ERCP, and gastric/duodenal/colonic barium or air-contrast studies, or abdominal CT scans, to reduce or inhibit gastrointestinal motility.

2. Used for gastrointestinal spasm, biliary colic, renal colic or hypermotility from various causes.

Spec: 1ml:20mg

Metformin / Glibenclamide Tablets (I)

Tablet
二甲双胍格列本脲片(I)
Indications

1. For type 2 diabetes patients whose blood glucose is not adequately controlled by diet control and/or exercise therapy alone.

2. As second-line therapy for type 2 diabetes patients whose blood glucose is not adequately controlled on sulfonylurea or metformin monotherapy.

Spec: Combination Formulation

Ribavirin Injection

Injection
利巴韦林注射液
Indications

Antiviral. Used for viral pneumonia and bronchitis caused by respiratory syncytial virus.

Spec: 2ml:0.1g

Domperidone Tablets

Tablet
多潘立酮片
Indications

For dyspepsia, bloating, belching, nausea, vomiting and abdominal distension/pain.

Spec: 10mg

Doxofylline Injection

Injection
多索茶碱注射液
Indications

Bronchial asthma, chronic asthmatic bronchitis and dyspnea caused by other forms of bronchospasm.

Spec: 10ml:0.1g

Omeprazole Enteric-Coated Capsules

Capsule
奥美拉唑肠溶胶囊
Indications

For gastric ulcer, duodenal ulcer, stress ulcer, reflux esophagitis and Zollinger-Ellison syndrome.

For short-term relief of heartburn and acid regurgitation caused by excess stomach acid.

Spec: 20mg

Pentoxifylline Injection

Injection
己酮可可碱注射液
Indications

Peripheral arterial disease (intermittent claudication or rest pain); inner-ear circulatory disorders.

Spec: 5ml:0.1g

Troxerutin Injection

Injection
曲克芦丁注射液
Indications

For occlusive syndrome, thrombophlebitis, capillary bleeding and similar conditions.

Spec: 2ml:0.1g

Telmisartan Capsules

Capsule
替米沙坦胶囊
Indications

For treatment of essential hypertension.

Spec: 40mg

Propyl Gallate Injection

Injection
棓丙酯注射液
Indications

For the prevention and treatment of cerebral thrombosis, coronary heart disease, and surgical complications such as thrombophlebitis.

Spec: 2ml:60mg

Aminomethylbenzoic Acid Injection

Injection
氨甲苯酸注射液
Indications

Mainly used for bleeding caused by excessive primary fibrinolysis, including acute and chronic, localized or systemic hyperfibrinolytic bleeding — commonly seen in cancer, leukemia, obstetric/gynecologic emergencies and severe liver disease.

Spec: 10ml:0.1g

Nicotinamide Injection

Injection
烟酰胺注射液
Indications

Mainly used to prevent and treat pellagra from niacin deficiency, coronary heart disease, viral myocarditis, rheumatic myocarditis and arrhythmias associated with mild digitalis toxicity; helps prevent cardiac conduction block.

Spec: 1ml:100mg

Cyclic AMP Injection

Injection
环磷腺苷注射液
Indications

For angina pectoris, myocardial infarction, myocarditis and cardiogenic shock. Helps relieve palpitation, breathlessness and chest tightness in rheumatic heart disease. May improve chemotherapy efficacy in acute leukemia and aid induction of remission. Also shows some benefit in chronic bronchitis in the elderly, various forms of hepatitis and psoriasis.

Spec: 2ml:20mg

Meglumine Adenosine Cyclophosphate Injection

Injection
环磷腺苷葡胺注射液
Indications

For heart failure, myocarditis, sick sinus syndrome, coronary heart disease and cardiomyopathy; also used as adjunctive therapy for arrhythmia.

Spec: 2ml:30mg

Lidocaine Hydrochloride Injection

Injection
盐酸利多卡因注射液
Indications

A local anesthetic and antiarrhythmic. Mainly used for infiltration anesthesia, epidural anesthesia, topical anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve block. Also used for ventricular premature beats and ventricular tachycardia after acute myocardial infarction, and for digitalis toxicity, and ventricular arrhythmias from cardiac surgery or catheterization. Generally ineffective for supraventricular arrhythmias.

Spec: 5ml:0.1g

Ligustrazine Phosphate Injection
(For Intravenous Use)

Injection
磷酸川芎嗪注射液(供静脉注射用)
Indications

For ischemic cerebrovascular disease (e.g. cerebral insufficiency, cerebral thrombosis, cerebral embolism).

Spec: 2ml:50mg

Valsartan Dispersible Tablets

Tablet
缬沙坦分散片
Indications

For treatment of mild to moderate essential hypertension.

Spec: 80mg

Citicoline Sodium Injection

Injection
胞磷胆碱钠注射液
Indications

For disturbance of consciousness following acute head injury and brain surgery.

Spec: 2ml:0.25g

Hydrotalcite Chewable Tablets

Tablet
铝碳酸镁咀嚼片
Indications

1. Chronic gastritis.

2. Acid-related gastric discomfort such as stomach pain, heartburn, acid eructation and bloating.

Spec: 0.5g

Azithromycin Tablets

Tablet
阿奇霉素片
Indications

1. Acute otitis media and acute tonsillitis caused by Streptococcus pyogenes.

2. Sinusitis, otitis media, acute bronchitis and acute exacerbation of chronic bronchitis caused by susceptible bacteria.

3. Pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Mycoplasma pneumoniae.

4. Urethritis and cervicitis caused by Chlamydia trachomatis and non-multidrug-resistant Neisseria gonorrhoeae.

5. Skin and soft tissue infections caused by susceptible bacteria.

Spec: 0.25g

加入我们 宣传首图

We Look Forward to Working With You

Whether it's a business partnership, a general inquiry, or a job application, our team will respond within 3 business days.

Address Zone A, Seventh Industrial Park, Huangtun Town, Jining High-tech Zone, Shandong
Phone 0537-5665669
Fax 0537-5665668
Postal Code 272104